You have 9 free searches left this month | for more free features.

sulindac

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukoplakia, Oral, Benign Tumors Trial in New York, Cochin, Trivandrum (sulindac, Placebo)

Completed
  • Leukoplakia, Oral
  • Benign Neoplasms
  • sulindac
  • Placebo
  • New York, New York
  • +2 more
Oct 23, 2020

Desmoid Tumor Trial in Monrovia (tamoxifen citrate, sulindac, laboratory biomarker analysis)

Completed
  • Desmoid Tumor
  • tamoxifen citrate
  • +2 more
  • Monrovia, California
    Children's Oncology Group
Feb 7, 2020

Inflammation, Cancer, Pain Trial in Tucson, Stony Brook (Sulindac)

Unknown status
  • Inflammation
  • +3 more
  • Sulindac
  • Tucson, Arizona
  • +1 more
Nov 28, 2018

Precancerous Condition Trial in Tucson, Stanford (sulindac, , laboratory biomarker analysis)

Completed
  • Precancerous Condition
  • sulindac
  • +2 more
  • Tucson, Arizona
  • +1 more
Nov 30, 2017

Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Boston (Bevacizumab, erlotinib, Sulindac)

Terminated
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Boston, Massachusetts
  • +1 more
Mar 15, 2017

Acute Myeloid Leukemia Trial in Boston (Cytarabine, Sulindac)

Withdrawn
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 15, 2017

Colon Cancer, Precancerous Condition, Rectal Cancer Trial in Rochester (oligofructose-enriched inulin, sulindac, )

Completed
  • Colon Cancer
  • +2 more
  • oligofructose-enriched inulin
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 28, 2016

Adenomatous Polyposis Coli Trial in Salt Lake City (Erlotinib, Sulindac, Placebo A)

Completed
  • Adenomatous Polyposis Coli
  • Salt Lake City, Utah
    Huntsman Cancer Institute
May 10, 2016

Colorectal Cancer, Liver Metastasis, Colorectal Adenocarcinoma Trial run by the NCI (Sulindac, Placebo, Validate assays and

Terminated
  • Colorectal Cancer
  • +2 more
  • Sulindac
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 22, 2015

Solid Tumor Trial in Rochester (sulindac, pharmacological study)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • sulindac
  • pharmacological study
  • Rochester, Minnesota
    Mayo Clinic Cancer Center
Apr 27, 2015

Precancerous Condition Trial in Orange (, eflornithine, sulindac)

Completed
  • Precancerous Condition
  • placebo
  • +3 more
  • Orange, California
    University of California Medical Center At Irvine-Orange Campus
Jan 12, 2015

Melanoma (Skin) Trial in Ireland (epirubicin HCl, sulindac, immunologic technique)

Completed
  • Melanoma (Skin)
  • epirubicin hydrochloride
  • +2 more
  • Cork, Ireland
  • +9 more
Dec 30, 2014

Focus of Study: Drug Response Biomarkers, Chemoprevention, Tumors Trial (difluoromethylornithine, Sulindac)

Withdrawn
  • Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
  • (no location specified)
Jul 28, 2014

Precancerous Condition, Stage I NSCLC, Tobacco Use Disorder Trial in Canada, United States (sulindac, )

Completed
  • Precancerous Condition
  • +2 more
  • sulindac
  • placebo
  • Scottsdale, Arizona
  • +5 more
May 7, 2014

Breast Cancer Trial in Philadelphia (docetaxel, sulindac)

Completed
  • Breast Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
May 5, 2014

Breast Cancer Trial in Tucson (sulindac, laboratory biomarker analysis)

Completed
  • Breast Cancer
  • sulindac
  • laboratory biomarker analysis
  • Tucson, Arizona
    Arizona Cancer Center at University of Arizona Health Sciences C
May 1, 2013

Colorectal Cancer Trial in Houston (Acetylsalicylic acid (Aspirin), Sulindac, Ursodiol)

Terminated
  • Colorectal Cancer
  • Acetylsalicylic acid (Aspirin)
  • +3 more
  • Houston, Texas
    M.D. Anderson Cancer Center at University of Texas
Jul 27, 2012

Colorectal Cancer Trial in New York (curcumin, rutin, quercetin)

Terminated
  • Colorectal Cancer
  • curcumin
  • +3 more
  • New York, New York
    Rockefeller University Hospital
Jan 26, 2011

Aberrant Crypt Foci Trial in New Brunswick (sulindac, curcumin)

Terminated
  • Aberrant Crypt Foci
  • New Brunswick, New Jersey
    Cancer Institute of New Jersey
Dec 10, 2009